Medical Corporation Accountability Act
HB552 creates the “Medical Corporation Accountability Act,” a health care transparency and anti-interference measure aimed at hospitals and health care providers in New Mexico. Beginning in 2026, hospitals that receive local or state funding must file annual reports with the Health Care Authority detailing their ownership structure, parent entities, operators, affiliations, land and facility ownership, related entities, and whether any involved parties are private equity funds or hedge funds. Hospitals must also report salary ranges for each type of health care provider and the total compensation of the hospital CEO, the owner’s CEO, and any parent entity CEO.
The bill also directs the Health Care Authority to adopt rules so that funded hospitals are subject to consistent reporting requirements and quality metrics, and to submit an annual summary report to the Legislature beginning in July 2026. In addition to disclosure requirements, HB552 restricts private equity funds and hedge funds from interfering with the professional judgment of health care providers or controlling decisions related to patient records, hiring and firing based on clinical competency, payer contracts, provider-to-provider contracts, billing and coding, and selection of medical equipment and supplies.
HB552 would add new reporting obligations for hospitals receiving state or local funding and would expand the Health Care Authority’s oversight role by requiring rulemaking and annual legislative reporting. It would also create new statutory limits on the conduct of private equity and hedge fund owners or affiliates in health care settings, effectively codifying a prohibition on certain forms of corporate control over medical decision-making and hospital operations. Hospitals, health care providers, and investment-backed health care entities would be the primary affected parties, especially those with complex ownership structures.
Based on the bill text and available context, the measure appears to be framed as a reform and accountability bill rather than a partisan or procedural measure. The sponsors’ choice of title and the bill’s focus on transparency, compensation disclosure, and protection of clinical judgment suggest support for stronger oversight of hospital ownership and private equity involvement in health care. No committee transcripts or vote history were provided, so there is no recorded floor or committee sentiment to assess beyond the bill’s apparent policy intent.
The main points of contention likely concern the bill’s restrictions on private equity and hedge funds, particularly whether the state is overreaching into business arrangements that affect hospital financing and management. Another likely issue is the breadth of the reporting requirements, including disclosure of ownership chains, affiliations, executive compensation, and salary ranges, which hospitals and investors may view as burdensome or sensitive. Supporters would likely emphasize transparency, patient protection, and preserving independent medical judgment, while opponents may argue the bill could discourage investment or complicate hospital operations.